Cystic Fibrosis Trial, Recruiting NCT05017766 Sponsor: University Hospital, Basel, Switzerland Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT05017766
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a confirmed urinary tract infection (UTI), pneumonia (including if you have had a lung transplant or have cystic fibrosis), or a serious deep-seated infection caused by one of these specific bacteria: E. coli, Klebsiella species, S. aureus, or P. aeruginosa
  • You are a "control" participant (someone without an active infection), meaning standard lab tests show no detectable bacteria and no signs of infection, and you have signed a general consent form
  • You are a "clinical control" participant who has a confirmed urinary tract infection, pneumonia, or deep-seated infection caused by one of the focus bacteria listed above, but no samples are being collected from you (confirm with trial site)

Who may not be able to join:

  • You have declined to allow your data or samples to be used for research, or have any other formal document refusing participation (such as an advance directive)
  • Your infection is caused by a bacterium other than the four specific focus bacteria listed in this trial
  • You are under 18 years of age
  • You are a control participant who has not signed the required general consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nina Khanna, Prof., University Hospital Basel, Division of Infectiology

Phone: +41 61 328 73 25

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Basel, Switzerland
Registry
ClinicalTrials.gov
Start date
3 December 2020
Est. completion
1 December 2028

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Clinical outcome: survival rate; Clinical outcome: mortality rate; Treatment response (binary: yes/ no)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov